Brain Tumor Treatment Market Research Report Information By Therapy (Targeted Therapy, Chemotherapy, Immunotherapy, Others), By Indication (Pituitary Tumors, Meningioma, Glioblastoma, Others), By Distribution Channel (Hospital Pharmacy, Retail & Online Pharmacy), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. BRAIN TUMOR TREATMENT MARKET, BY THERAPY

6.1. Overview

6.2. Targeted Therapy

6.3. Chemotherapy

6.4. Immunotherapy

6.5. Others

7. BRAIN TUMOR TREATMENT MARKET, BY INDICATION

7.1. Overview

7.2. Pituitary Tumors

7.3. Meningioma

7.4. Glioblastoma

7.5. Others

8. BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.1. Overview

8.2. Hospital Pharmacy

8.3. Retail & Online Pharmacy

9. BRAIN TUMOR TREATMENT MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Brain tumor treatment Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Brain tumor treatment Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. F. Hoffmann-La Roche Ltd (U.S.)

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Novartis AG (Switzerland)

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Merck & Co. Inc. (U.S.)

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Pfizer Inc. (U.S.)

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Amneal Pharmaceuticals LLC. (U.S.)

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Amgen Inc. (U.S.)

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. NextSource Pharmaceuticals, LLC (U.S.)

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. EMCURE PHARMACEUTICALS (INDIA)

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Siemens Healthineers AG

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Dr. Reddy’s Laboratories Ltd.

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 BRAIN TUMOR TREATMENT MARKET, SYNOPSIS, 2018-2032

TABLE 2 BRAIN TUMOR TREATMENT MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 4 BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 5 BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 9 US: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 10 US: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 11 US: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 12 CANADA: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 13 CANADA: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 14 CANADA: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 3 EUROPE: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 4 GERMANY: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 5 GERMANY: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 6 GERMANY: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 7 FRANCE: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 8 FRANCE: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 9 FRANCE: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 10 ITALY: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 11 ITALY: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 12 ITALY: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 13 SPAIN: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 14 SPAIN: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 15 SPAIN: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 16 UK: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 17 UK: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 18 UK: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 25 JAPAN: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 26 JAPAN: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 27 JAPAN: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 28 CHINA: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 29 CHINA: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 30 CHINA: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 31 INDIA: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 32 INDIA: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 33 INDIA: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 34 AUSTRALIA: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 35 AUSTRALIA: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 36 AUSTRALIA: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 49 AFRICA: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 50 AFRICA: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 51 AFRICA: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: BRAIN TUMOR TREATMENT MARKET, BY THERAPY, 2018-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: BRAIN TUMOR TREATMENT MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: BRAIN TUMOR TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE BRAIN TUMOR TREATMENT MARKET

FIGURE 3 MARKET DYNAMICS FOR THE BRAIN TUMOR TREATMENT MARKET

FIGURE 4 BRAIN TUMOR TREATMENT MARKET, SHARE (%), BY THERAPY, 2022

FIGURE 5 BRAIN TUMOR TREATMENT MARKET, SHARE (%), BY INDICATION, 2022

FIGURE 6 BRAIN TUMOR TREATMENT MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022

FIGURE 7 BRAIN TUMOR TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: BRAIN TUMOR TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 EUROPE: BRAIN TUMOR TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 ASIA-PACIFIC: BRAIN TUMOR TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 REST OF THE WORLD: BRAIN TUMOR TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 BRAIN TUMOR TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 13 F. HOFFMANN-LA ROCHE LTD (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 F. HOFFMANN-LA ROCHE LTD (U.S.): SWOT ANALYSIS

FIGURE 15 NOVARTIS AG (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 NOVARTIS AG (SWITZERLAND): SWOT ANALYSIS

FIGURE 17 MERCK & CO. INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 MERCK & CO. INC. (U.S.): SWOT ANALYSIS

FIGURE 19 PFIZER INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 PFIZER INC. (U.S.): SWOT ANALYSIS

FIGURE 21 AMNEAL PHARMACEUTICALS LLC. (U.S.).: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 AMNEAL PHARMACEUTICALS LLC. (U.S.).: SWOT ANALYSIS

FIGURE 23 AMGEN INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 AMGEN INC. (U.S.): SWOT ANALYSIS

FIGURE 25 NEXTSOURCE PHARMACEUTICALS, LLC (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 NEXTSOURCE PHARMACEUTICALS, LLC (U.S.): SWOT ANALYSIS

FIGURE 27 EMCURE PHARMACEUTICALS (INDIA): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 EMCURE PHARMACEUTICALS (INDIA): SWOT ANALYSIS

FIGURE 29 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS

FIGURE 31 DR. REDDY’S LABORATORIES LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 DR. REDDY’S LABORATORIES LTD.: SWOT ANALYSIS